Abstract:We have retrospectively reviewed 63 cases of encephalic toxoplasmosis (ET) in HIV-infected patients in order to determine clinical and radiological characteristics, the diagnostic value of serologic determinations, and the response to antioxoplasmic therapy. ET was the AIDS-defining condition in 44% of the patients. Eighty of the patients had a CD4 cell count < 100/microliters when ET was diagnosed. Only 4.8% of the patients had been taking anti-Pneumocytis carinii prophylaxis with cotrimoxazol. The most frequent clinical presentation was focal neurologic signs in 80.9% of the patients, with headache and fever in 53.3% and 42.4%, respectively. The most frequent cerebral CT finding was hipodense lesions (92%) with ring enhancement (68.9%). They were most frequently had a hemisferic location. Seroconversion was detected in two patients (6%), whereas 55 patients had serologic evidence of latent infection by Toxoplasma gondii (87.3%). Ninety eight percent of the patients were treated with sulphadiazine plus pyrimethamine. However, such therapy should be discontinued in 22% of them and switched to clindamycin plus pyrimethamine. The overall mortality rate during the acute phase of the disease was 7.9%, but 41.4% of the survivors exhibited neurologic sequelae. Relapsing ET was detected in 33.3% of the patients, and it was usually due to discontinuation of treatment. The mean survival time after the diagnosis of ET was 11.5 months. ET is the most common opportunistic infection of the central nervous system among our AIDS patients. Primary prophylaxis for toxoplasmic infection seems advisable in our epidemiologic environment, when CD4 cell count is less than 200/microliters and there is serologic evidence of latent infection. Acute ET usually has a good response to therapy, and the acute mortality rate is low. However, most of the survivors will remain with neurologic sequelae. The high frequency of adverse effects to sulphamide therapy with clindamycin make the need of alternative treatment strategies urgent.

The Imaging Diagnostic Criteria of AIDS-related Cerebral Toxoplasmosis in China

Expert Consensus for Diagnostic Imaging of Acquired Immunodeficiency Syndrome-Related Cerebral Toxoplasmosis

The therapeutics and management of cryptococcus-related immune reconstitution inflammatory syndrome in AIDS patients

Value of imaging diagnosis of pulmonary infections in patients with acquired immunodeficiency syndrome

MRI Characterization of Toxoplasma Encephalopathy in Patients with AIDS

Cerebral toxoplasmosis mimicking stroke in a woman living with undiagnosed HIV

Imaging Characterization of Cryptococcal Meningoencephalitis

Application of Stereotactic Biopsy for Diagnosing Intracranial Lesions in Patients with AIDS in China

Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China

Coinfection of cerebral toxoplasmosis and neurosyphilis as the first manifestation of AIDS

[Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients]

Difficulty in diagnosing intracranial infection caused by Mycobacterium avium in an AIDS patient: case report and review of the literature

Imaging Analysis on Acquired Immunodeficiency Syndrome Combined with Pulmonary Tuberculosis

^99Mtc—ecd Brain SPECT Imaging in Patients with Acquired Immunodeficiency Syndromes

Stroke-Like Presentation of Cerebral Toxoplasmosis: Two HIV-Infected Cases

The clinical characteristics of 16 cases of AIDS complicated with cryptococcal meningtis

A Case of Acquired Immunodeficiency Syndrome with Cerebral Sparganosis and Review of the Literature.

Evaluation of a rapid ELISA technique for detection of circulating antigens of Toxoplasma gondii.

Use of Indirect Immunofluorescence Microscopy in the Diagnosis of AIDS Patients with Pneumocystis Pneumonia

Imaging diagnosis of pulmonic damage in patients with AIDS

Clinical Analysis of Acquired Immunodeficiency Syndrome with Neurological Complications